Ionis partner Biogen announces topline results from Phase 2 CELIA study of diranersen (BIIB080): first study to show reduction in tau pathology and cognitive benefit in patients with early Alzheimer’s disease

🌐 Yahoo Finance — 2026-05-14

Ionis Pharmaceuticals and Biogen have announced significant results from a Phase 2 study of a treatment for early Alzheimer's disease. This study showcases early cognitive benefits and reduction in tau pathology.

Health AI & Tech Alzheimer's clinical study Biogen Ionis Pharmaceuticals cognitive benefits

Read original source →

Runner dies during charity event
The Sydney Morning Herald — 2026-05-24
Ebola toll in DR Congo over 200, Uganda and 10 other African countries also at risk
South China Morning Post — 2026-05-24
Mum claims primary school bullies broke son’s arm, Kedah Education Dept investigating
Malay Mail — 2026-05-24
Ministry urges information to assist probe into Pasir Gudang pupil abuse allegations
Borneo Post — 2026-05-24
China’s desire for endless youth is wiping out donkeys – can scientists help?
South China Morning Post — 2026-05-24
Nigeria’s First Lady seeks an end to child marriage and obstetric fistula
Premium Times Nigeria — 2026-05-24

Ionis partner Biogen announces topline results from Phase 2 CELIA study of diranersen (BIIB080): first study to show reduction in tau pathology and cognitive benefit in patients with early Alzheimer’s disease

AI Summary

Related Articles

Runner dies during charity event

Ebola toll in DR Congo over 200, Uganda and 10 other African countries also at risk

Mum claims primary school bullies broke son’s arm, Kedah Education Dept investigating

Ministry urges information to assist probe into Pasir Gudang pupil abuse allegations

China’s desire for endless youth is wiping out donkeys – can scientists help?

Nigeria’s First Lady seeks an end to child marriage and obstetric fistula